Shenzhen Sangel is a venture capital firm that makes investments in biomedical companies.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Shenzhen Sangel is a venture capital firm that makes investments in biomedical companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2020 | Virogin Biotech | Series B | - |
7/2016 | Vivolight | Series A | 1.5M |
12/2021 | SparX Group | Series B | 30M |
10/2020 | Sirnaomics | Series D | 0 |
1/2018 | KBP Biosciences | Series A | 0 |
10/2020 | 3D Medicines | Private Equity Round | 0 |
1/2018 | Ultivue | Series B | 20M |
4/2015 | Science For Life | Series A | 1.6M |
2/2019 | Magpie Pharmaceuticals | Series B | 14.8M |
7/2015 | Vivolight | Angel Round | 484.7k |
10/2019 | Denovo Biopharma | Series B | 42.6M |
2/2017 | Virogin Biotech | Series A | 5M |
12/2020 | Denovo Biopharma | Series D | 0 |
5/2018 | Refuge Biotechnologies | Series B | 0 |
3/2016 | Virogin Biotech | Series A | 7M |
5/2017 | Landing Medical High Technology | Series B | - |
4/2017 | EZlifeBio | Series A | 9.9M |
6/2017 | CosBeauty | Series B | 2.9M |
4/2015 | baolaitong.com | Angel Round | 485k |
8/2018 | Predicine Huidu Medical Technology | Series A | - |
4/2019 | BrainNow | Series A | - |
3/2022 | Yiyao Technology | Angel Round | 1.6M |
12/2010 | MAXCOM | Funding Round | 7.5M |
3/2021 | Aucta Pharmaceuticals China | Series A | - |
7/2012 | Wtoqa | Angel Round | 469.6k |
3/2022 | Yiyao Technology | Angel Round | 0 |
12/2021 | SparX Group | Series B | 0 |
3/2021 | Aucta Pharmaceuticals China | Series A | - |
12/2020 | Denovo Biopharma | Series D | 0 |
10/2020 | Sirnaomics | Series D | 0 |
10/2020 | 3D Medicines | Private Equity Round | 0 |
6/2020 | Virogin Biotech | Series B | - |
10/2019 | Denovo Biopharma | Series B | 0 |
4/2019 | BrainNow | Series A | - |
2/2019 | Magpie Pharmaceuticals | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|